Who invested in GV20 Therapeutics?
GV20 Therapeutics's investors include IDG Capital and Coatue.

Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2025, from 1 source
GV20 Therapeutics's investors include IDG Capital and Coatue.
GV20 Therapeutics has raised 1 round since 2025, none with a disclosed amount.
GV20 Therapeutics's most recent round was a Venture in Nov 2025.
GV20 Therapeutics's first round on record, in Nov 2025, was backed by IDG Capital and Coatue.
GV20 Therapeutics's latest named round is a Venture, in Nov 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.